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Abstract
In Plasmodium falciparum-infected red blood cells (RBCs), the flavoenzyme glutathione reductase (GR) regenerates reduced
glutathione, which is essential for antioxidant defense. GR utilizes NADPH produced in the pentose phosphate shunt by
glucose-6-phosphate dehydrogenase (G6PD). Thus, conditions affecting host G6PD or GR induce increased sensitivity to
oxidants. Hereditary G6PD deficiency is frequent in malaria endemic areas and provides protection against severe malaria.
Furthermore, GR deficiency resulting from insufficient saturation of the enzyme with its prosthetic group FAD is common.
Based on these naturally occurring phenomena, GR of malaria parasites and their host cells represent attractive antimalarial
drug targets. Recently we were given the opportunity to examine invasion, growth, and drug sensitivity of three P.
falciparum strains (3D7, K1, and Palo Alto) in the RBCs from three homozygous individuals with total GR deficiency resulting
from mutations in the apoprotein. Invasion or growth in the GR-deficient RBCs was not impaired for any of the parasite
strains tested. Drug sensitivity to chloroquine, artemisinin, and methylene blue was comparable to parasites grown in GR-
sufficient RBCs and sensitivity towards paraquat and sodium nitroprusside was only slightly enhanced. In contrast,
membrane deposition of hemichromes as well as the opsonizing complement C3b fragments and phagocytosis were
strongly increased in ring-infected RBCs of the GR-deficient individuals compared to ring-infected normal RBCs. Also, in one
of the individuals, membrane-bound autologous IgGs were significantly enhanced. Thus, based on our in vitro data, GR
deficiency and drug-induced GR inhibition may protect from malaria by inducing enhanced ring stage phagocytosis rather
than by impairing parasite growth directly.
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Introduction
The tripeptide glutathione (c-glutamylcysteinylglycine)ispresentin
millimolar concentrations in the malaria parasite Plasmodiumfalciparum
as well as in the hostred blood cell(RBC) [1–5]. Reduced glutathione
( G S H )p l a y sa ne s s e n t i a lr o l ei na n t i o x i d a n td e f e n s ei nb o t hp a r a s i t e
and host cell [1–5]. Parasite GSH supports cell growth by providing
electrons for deoxyribonucleotide synthesis and takes part in
detoxifying heme, a product of hemoglobin digestion [6]. Further-
more, GSH is the coenzyme of the glyoxalase system, which
detoxifies methylglyoxal [7], and of glutathione S-transferase (GST)-
based reactions. GSTs contribute to the detoxification of exogenous
and endogenous cytotoxic metabolites. In Plasmodium,G S Ti s
involved in peroxide detoxification and the binding of parasitotoxic
heme as well as in the development of drug resistance [8]. The
flavoenzymeglutathionereductase(GR,EC1.8.1.7)reducesoxidized
glutathione (GSSG) back to GSH [3,9]. Due to its central position in
redox control, P. falciparum GR (PfGR) is ranked number one in the
list of proposed antimalarial drug targets for Plasmodium (http://
tdrtargets.org/), and a wide range of respective drug development
approaches is currently being followed [9–11]. In addition, the
inhibition of RBC GR has been proposed as an approach to reduce
the risk of multidrug resistance in malaria parasites [9].
In the GR-catalyzed reaction, reducing equivalents are provided
by NADPH. NADPH is generated in the first half of the hexose
monophosphate shunt by glucose-6-phosphate dehydrogenase
(G6PD). Therefore, G6PD (producer of NADPH) as well as GR
(utilizer of NADPH) are equally essential to maintain GSH
homeostasis in the parasite-host unit [2,4]. Mutations affecting
either G6PD or GR might thus induce similar metabolic and
functional consequences in the RBC. G6PD deficiency occurs in
numerous genotypes, some of which are polymorphic and
particularly frequent in areas where malaria is or was endemic
[12–14], affecting approximately 330 million people worldwide
[15]. Decreased GR activity due to low saturation with FAD is also
common in certain malaria-endemic regions [16]. By contrast,
hereditary GR deficiency is rare [17], and only recently a full
biochemical and molecular characterization of a GR mutation
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7303leading to complete GR deficiency has been performed [18]. In this
patient, RBCs and leukocytes did not contain any GR activity, and
the GR protein could not be detected by Western blotting. DNA
sequencing revealed a 2242-bp deletion, starting at nucleotide +658
in intron 11 and ending at nucleotide 639 in the 39 untranslated
region of exon 13 of the GR gene, which is located on chromosome
8. As a result, translated GR missed the complete dimerization
domain, resulting in an inactive enzyme [18].
In view of (a) the potentially similar metabolic effects of G6PD and
GR deficiency, (b) the well documented protection from severe
falciparum m a l a r i aa f f o r d e db yG 6 P Dd e f i c i e n c y[ 1 4 , 1 9 ]a n d( c )t h e
fact that P. falciparum GR and human GR represent most promising
antimalarial drug targets, we studied invasion and growth of several
P. falciparum s t r a i n si nG R - d e f i c i e n tR B C sa sw e l la st h es t a g e -
dependent pathological alterations induced by parasite growth in
these erythrocytes. We directly compared those changes to GR-
sufficient control cells as well as to analogous data obtained with
malaria-infected G6PD-deficient RBCs and to senescent RBCs
[13,20,21]. Analogies with RBCs from patients with sickle-cell trait,
b-thalassemia [22], and pyruvate kinase deficiency[23] are discussed.
Results
Unless otherwise indicated, all experiments reported below were
performed with RBCs from the index patient.
Invasion and multiplication of P. falciparum grown in GR-
deficient RBCs
Twenty-four hours after inoculation of GR-deficient RBCs with
malarial parasites (strains 3D7 or K1, experiment 1, see Materials
and Methods), ring stages of Plasmodium were detectable in all
wells. As determined by Giemsa staining and by having an
experienced technician count infected cells under the light
microscope, the parasitemia for the 3D7 strain was 3.960.5% in
the GR-deficient cells and 4.060.4% in the controls. This
indicated that Plasmodium is able to invade GR-deficient RBCs as
efficiently as normal RBCs. Subsequently, parasites were grown in
the respective RBC cultures for four complete 48-h cycles,
showing a mean multiplication rate of 4.960.3 per RBC cycle
for the GR-deficient RBCs, as well as 4.3 (0
+ blood) and 6.5 (A
+
blood) for the controls (mean 5.460.5; data are given in Table 1).
Also, in the second experiment (strain 3D7, see Methods), all RBC
samples (index patient and three controls) were efficiently invaded by
the parasites. Forty-eight hours later about 4% infected RBCs
(IRBCs) were again determined in all 4 cultures. After splitting and
another 48-h cycle, a very similar parasitemia (given in the following
for 3D7) was determined in all samples (9.860.3% in the GR-
deficient cells, 9.360.4% in the controls). Also the percentages of ring
stages (3662% in the patient and 3763% in the controls) and
trophozoite/schizont stages (6461% in the patient, 6263% in the
controls) did not differ significantly. The morphology of the parasites
as determined by light microscopy after Giemsa staining was
unchanged throughout the experiments (data not shown). In a
separate set of experiments performed in the other participating
laboratory in Turin with the Palo Alto parasite strain, similar data
were obtained, showing that the invasion rate of GR-deficient RBCs
was as high as that of control RBCs (30% parasitemia at 19 h after
inoculation with 6.4% schizonts), and regular development into
trophozoites was observed on day 2 (30% parasitemia).
GR activity, total glutathione content and drug sensitivity
of P. falciparum grown in GR-deficient RBCs
Malarial parasites grown in GR-deficient RBCs were tested for
total glutathione content, GR activity, and their sensitivity towards
redox-active antimalarials as well as inducers of oxidative and
nitrosative stress. Data were collected in two independent
experiments (including venipuncture and shipment of the blood
samples) with different controls and two different parasite strains
(K1 and 3D7). Before determining the above parameters, parasites
were grown for 4–5 cycles (corresponding to 8–10 days) in the
respective RBCs. Late trophozoite stages were then isolated as
described in the Materials and Methods section and directly used
for the determination of GR activity and glutathione content.
Antimalarial drugs and pro-oxidant agents were added to the ring
stages of the parasites in order to determine their IC50 values.
In both experiments the parasites displayed a glutathione
content of about 70 nmol/mg protein, which did not differ
between parasites grown in GR-deficient and normal host cells
(Table 1). However, in the parasites grown in GR-deficient cells,
GR activity was found to be significantly reduced to 61%
(experiment 1, see Table 1) of control values. A comparable value
(66% of control activity) was determined in experiment 2.
The IC50 values for CQ, artemisinin, and methylene blue were
very similar between parasites grown in GR-deficient RBCs and in
normal control RBCs (Table 1). This was verified in both
experiments and for both parasite strains K1 and 3D7. However,
the IC50 values of the superoxide generating agent paraquat and of
sodium nitroprusside were found to be significantly lower in
parasites grown in GR-deficient RBCs than in controls (Table 1).
Membrane binding of hemichromes, complement C3
fragment, autologous IgG, and phagocytosis in ring
stage-infected GR-deficient RBCs
Membrane-bound hemichromes, indicators of oxidative mem-
brane damage and inducers of RBC membrane modifications
producing enhanced phagocytosis [20–22], were measured in ring
Table 1. Comparison of growth and biochemical properties
of P. falciparum grown in GR-deficient and control RBCs.
GR-deficient
RBCs Control RBCs
aTotal glutathione in the parasite
(3D7, exp. 1+2) [nmol/mg protein] 6862.1 7361.4
bGR activity in parasites [mU/mg] 160662 7 0 614* (P=0.002)
Parasite multiplication rate per RBC
cycle (3D7, exp. 1)) 4.960.3 5.460.5
IC50 chloroquine (3D7) [nM] 8.260.2 (4.960.2) 8.060.2 (A
+)( 5 . 9 60.6)
IC50 chloroquine (K1) [nM] 160610 190611 (A
+)
IC50 methylene blue (3D7) [nM] 3.960.2 (4.260.3) 3.860.2 (A
+)( 4 . 2 60.3)
IC50 methylene blue (K1) [nM] 8.860.5 8.160.4 (A
+)
IC50 artemisinin (3D7, exp. 2) [nM] 1460.5 1660.8
IC50 paraquat (3D7, exp. 2) [mM] 42625 3 63* (P=0.04)
IC50 SNP (3D7, exp. 2) [mM] 5.860.3 1160.8* (P=0.006)
Experiment 1 refers to the index patient and the A
+ blood group control,
experiment 2 (data given in brackets or indicated as exp. 2) refers to index
patient and mean values of 3 controls. All values given represent mean values
6 SEM of the different individuals included and two to three parallel
determinations per sample.
aBefore determining the biochemical parameters in the parasites, P. falciparum
was grown over 4–5 cycles (corresponding to 8–10 days) in the respective
RBCs. Control cells had the same blood group (0
+) as the patient’s.
b*Indicates significant differences (P,0.05) between GR-deficient cells and
controls.
doi:10.1371/journal.pone.0007303.t001
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and individual 3 (sister), all homozygous for the GR deficiency,
and were compared to ring stage-infected normal RBCs. As shown
in Fig. 1A, parasite growth significantly increased membrane-
bound hemichromes in all three GR-deficient individuals.
Membrane binding of complement fragments C3 and C3b2 and
autologous IgG, two powerful opsonins known to be instrumental
in inducing phagocytosis, were assayed in ring-infected RBCs in
the index patient as well as in individuals 2 and 3. Opsonic
complement C3 fragments C3b/C3b2 were measured as C3c, a
stable C3 derivative, making use of anti-C3c antibodies, as detailed
in the Materials and Methods section. As shown in Figure 1B–C,
membrane deposition of complement fragment C3c was remark-
ably increased in all three GR-deficient individuals, while binding
of IgG was strongly enhanced in the index patient but unchanged
in the other two individuals. In general, changes observed in the
index patient were more pronounced compared to the other two
GR-deficient individuals. Phagocytosis was assayed with the
human monocytic cell line THP-1 (Figure 2A) and with human
mononuclear cells (Figure 2B). Both phagocytic cell types
displayed increased phagocytosis of ring-infected cells from all
three GR-deficient individuals. Again the effect was more
pronounced in the index patient. Co-cultivated, non-infected
normal or deficient RBCs were not phagocytosed in significant
amounts (Figure 2A–B). Trophozoites were phagocytosed more
intensely than ring stages, with minor differences between GR-
deficient and control RBCs (Figure 2B).
The data on membrane-bound hemichromes, complement C3c
fragment, IgG, and phagocytosis were obtained from single
samples from the GR-deficient individuals and 3–4 normal
controls. Except for hemichromes where 3–4 repeats were
constantly performed and formal statistical treatment was possible,
the paucity of sample material did not allow us to perform a
sufficient number of repeats in the GR-deficient samples.
Therefore representative values are shown in Figures 1 and 2.
The supplementary figure S1 compares results shown in Figures 1
and 2 with an additional series of normal control rings obtained
using 24–36 h old normal blood from 7 healthy Italian donors. In
general, SDs were distinctly lower in the Italian control series,
increasing the robustness of comparisons.
Discussion
RBC mutations leading to enhanced ring phagocytosis
A relatively small number of mutations affecting hemoglobins
and RBC enzymes are present in large numbers in human
populations. It is accepted that these widespread polymorphisms
afford protection against falciparum malaria [24–26]. A group of
these conditions including sickle cell anemia, b-thalassemia,
possibly hemoglobins C [27,28] and E [29], as well as G6PD
deficiency [14,20] and PK deficiency [23] appear to provide
antimalarial protection based on a common mechanism [20,22].
The aberrant RBCs are characterized by an increased production
of reactive oxygen species (ROS) (hemoglobin mutants), or
decreased antioxidant defense (G6PD deficiency, PK deficiency
[23]). Non-infected, mutant RBCs display slight but significantly
increased membrane deposition of hemichromes accompanied by
low-grade but distinct enhancement of phagocytic uptake
[20,22,23]. Parasites growing in any of the aforementioned
mutated cells induce typical modifications in the host RBCs
which start manifesting at ring stage. Normal RBCs harboring ring
stages show little band 3 aggregation, poor opsonization, and
slightly enhanced phagocytic recognition and uptake [30]. By
contrast, rings growing in mutant RBCs sequentially display (1)
Figure 1. Membrane-bound hemichromes, complement C3c
fragment, and autologous IgG in GR-deficient and GR-sufficient
RBCs. Shown are membrane-bound hemichromes (panel A), comple-
ment C3c fragment (panel B) and autologous IgG (panel C) in ring-
infected and non-infected GR-deficient RBCs from the index patient,
brother (individual 2) and sister (individual 3) of index patient, and from
normal GR-sufficient controls. Black bars indicate ring-infected RBCs;
open bars, non-infected RBCs. Hemichromes are expressed as pmoles/mg
membraneprotein.Mean valuesofindexpatient, individuals2 and3,and
normal controls (mean6SD, n=2–4) are shown. Hemichromes were
significantly higher (p,0.02) in the ring-infected RBCs of the index
patient andindividuals2and3 comparedtoring-infectedRBCsofnormal
controls. Complement C3c fragment and autologous IgG are expressed
as Mean Fluorescence Intensity. Representative data of GR-deficient
individuals and mean values of normal controls (mean6SD, n=2–3). For
experimental details see Materials and Methods.
doi:10.1371/journal.pone.0007303.g001
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(2) oxidative band 3 aggregation, (3) increased affinity for naturally
circulating IgG – notably anti-(band 3) IgG, (4) activation of the
complement system and generation of C3 opsonic fragments, (5)
opsonization by increased deposition of autologous IgG and C3
opsonic fragments, and finally (6) remarkably enhanced recogni-
tion and phagocytosis by monocytes/macrophages [20–23]. This
sequence of events, eventually resulting in enhanced phagocytic
uptake, is very similar to changes occurring in the normal human
RBC during the very last phase of its lifespan of 12064 days [21].
Advantages of enhanced ring phagocytosis for the
malaria patient
Enhanced and preferential phagocytosis of ring-parasitized mutant
RBCs may be advantageous to the host in two ways: (i) via reduction of
parasite growth and parasite density, observed for example in patients
with HbAS and b-thalassemia trait [24,25], and (ii) via rapid digestion
of phagocytosed rings by monocytes and the frequent repetition of this
process without loss of efficiency [31]. By contrast, phagocytosis of
hemozoin-containing mature parasites inhibits the ability of monocytes
to repeat the phagocytic process [31], enhances their production of
inflammatory cytokines [32], and impairs their ability to kill ingested
pathogens [33], to express MHC class II and other membrane antigens
upon interferon-gamma stimulation [34], and to correctly present
antigens [35]. Another way enhanced ring phagocytosis may be
advantageous to the host is bylowering the number of trophozoites and
schizonts adhering to endothelia in specific organs and provoking there
severe clinical conditions such as cerebral malaria, placental malaria,
and possibly dyserythropoiesis-based anemia [36,37]. Other protection
mechanisms probably concur with this based on enhanced ring-
phagocytosis of mutant RBCs underscored here. For example,
decreased adhesion to endothelia has been suggested to be involved
in anti-malaria defense in sickle-cell trait [38,39] and Hb AC/CC [40].
ApoGR-deficient red blood cells as host cells for P.
falciparum
GR deficiency and G6PD deficiency might show similar character-
istics as far as instability and impaired regeneration of GSH from
GSSG is concerned [41,17]. However, G6PD deficiency may have
more severe functional consequences for the RBC than GR deficiency,
since insufficient formation of NADPH leads to an inadequate supply
of reducing equivalents to both the glutathione and the thioredoxin
system, whereas the absence of GR activity in non-parasitized RBCs is
obviously well compensated [18]. As indicated already by previous
studies, rather stable GSH concentrations are present in the non-
parasitized RBCs [17]. This might be due to enhanced GSH synthesis
[17] but could also be the result of upregulation of the pentose
phosphate shunt and by components of the thioredoxin system. Also in
the host-parasite unit, the absence of RBC GR seems to be well
tolerated under cell culture conditions and in the absence of oxidative
s t r e s s o r s .T h i si ss h o w nb yn o r m a li n v a s i o na n dg r o w t ha sw e l la sb y
comparable glutathione levels detected in both parasites grown in GR-
deficient and normal RBCs. Interestingly, GR activity was found to be
downregulated by 40% in the parasite compartment. The observation
that this decrease is not reflected in the glutathione levels can be
explained by the fact that GR is working intracellularly with large spare
capacity [9, and references therein]. This phenomenon, however,
needs to be studied in further detail. An efficient adaptation to the lack
of host cell GR in our in vitro system was furthermore supported by the
fact that the IC50 values for CQ, artemisinin, and methylene blue were
very similar when comparing parasites grown in GR-deficient RBCs
and in GR-sufficient control RBCs. All three antimalarial drugs are
known to interfere with redox metabolism: CQ inhibits heme
polymerization, leading to enhanced oxidative stress; artemisinin as
an endoperoxide is able to increase ROS concentrations; methylene
blue is a known redox cycler and PfGR inhibitor [4,5]. Only when
incubating parasitized RBCs with micromolar concentrations of
paraquat [42] or of the nitric oxide releasing agent sodium
nitroprusside, IC50 values were significantly lower in parasites grown
in GR-deficient RBCs than in the controls. This result suggests that it
might be possible to demonstrate the higher redox susceptibility of GR-
deficient parasitized RBCs in an in vitro assay by imposing oxidative or
nitrosative stress.
Enhanced ring phagocytosis associated with GR
deficiency
Data presented here show that malaria-infected GR-deficient
RBCs behave very similarly to infected G6PD-deficient RBCs
Figure 2. Phagocytosis of GR-deficient and GR-sufficient RBCs.
Shown is the phagocytosis by THP-1 cells (panel A) of ring-infected and
non-infected GR-deficient RBCs from the index patient, brother
(individual 2) and sister (individual 3) of the index patient, and from
normal GR-sufficient controls. Phagocytosis by human monocytes
(panel B) of ring- and trophozoite-infected and non-infected GR-
deficient RBCs from the index patient, brother (individual 2) of the index
patient, and from normal GR-sufficient controls. Black bars indicate
ring-/trophozoite-infected RBCs; open bars, non-infected RBCs. Phago-
cytosis is expressed as the number of ingested RBCs per phagocyte.
Representative data of index patient, individuals 2 and 3, and mean
values of normal controls (mean6SD, n=3) are shown. For experimen-
tal details see Materials and Methods.
doi:10.1371/journal.pone.0007303.g002
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they supported the growth and multiplication of CQ-sensitive and
-resistant P. falciparum strains in a manner similar to normal RBCs.
Second, as expected from the enhanced sensitivity to oxidation,
infection enhanced heme and hemichrome deposition in deficient
RBCs by a factor of approximately 3. Third, membrane
deposition of opsonins such as C3 complement fragments and
autologous IgG, and phagocytosis, were also found to be increased
when ring stages were grown in GR-deficient RBCs. The two
other homozygous GR-deficient individuals examined here
(brother and sister of the index patient) also showed enhanced
binding of C3 complement fragment and increased phagocytosis
whereas IgG binding was not increased. These differences remain
to be elucidated in further detail. All three individuals studied were
identical with respect to the complete lack of GR activity.
However, other metabolic or immunologic states and predisposi-
tions, which we do not know and therefore cannot control, might
lead to the observed differences.
Endemic GR deficiency caused by undersaturation with
FAD
Complete absence of RBC GR is very rare [12,17,18]. This
defect evidently did not arise in parallel to malaria expansion in
humans to provide protection. However, impairment of GR
activity is widespread and geographically coincident with past or
present occurrence of malaria. Since GR is a flavoprotein critically
dependent on FAD [43], flavin-deficient RBCs would contain
decreased GR activity. In fact, riboflavin deficiency is widespread
in underdeveloped countries due to low dietary intake [44,45].
Several studies have shown that a reduced riboflavin status and
non-genetic low GR activity are associated with lower Plasmodium
parasitemia in humans [46] and in animal [47] models and are
frequently found in malaria-endemic areas [48]. Furthermore,
high prevalence of familial flavin-deficient RBCs not due to
dietary riboflavin deficiency was detected in parts of Italy where
malaria used to be prevalent, namely the Maremma region in
Tuscany, the delta region of the river Po, and coastal areas in
Sardinia [48–50]. Interestingly, in Sardinia [50] micro-regional
accumulation in villages formerly exposed to malaria was observed
for carriers of the putative malaria-protective low-activity GR and
FMN-dependent pyridoxine phosphate oxidase [50]. Accumula-
tion in the same villages was previously observed for carriers of b-
thalassemia and G6PD deficiency [51]. Finally, low GR activity
was found to be frequently associated with other malaria-
protective mutations such as sickle-cell anemia and b-thalassemia
[52–55].
Conclusions
In conclusion, rare RBC mutations such as PK deficiency and
GR deficiency resist malaria infection and may provide protection
by the same paradigm applicable to widespread mutations such as
those affecting hemoglobin, G6PD, or membrane proteins. Thus
the pharmacologic inhibition of parasite and/or host cell GR
might lead to metabolic consequences proven by nature to be
effective against the parasite. Indeed the inhibition of RBC GR
has been proposed as a feasible antimalarial approach likely to
reduce the risk of resistance development [9]. Normal RBCs
pretreated with high doses of the cytostatic agent carmustine
(BCNU) have no detectable GR activity. These RBCs do not serve
as host cells of P. falciparum in vitro unless the medium contains high
levels of glutathione. Thus, in contrast to genetically GR-deficient
RBCs, RBCs rendered GR-deficient by BCNU appear to be
unable to maintain sufficient GSH levels, possibly because the high
BCNU doses also affect the GSH synthesizing enzymes [56].
Nevertheless erythrocytes pretreated with lower doses of nitroso-
ureas in vivo or in vitro are probably suitable for corroborating and
extending the findings of this present study [57].
When testing GR-inhibitors as antiplasmodial agents it should
be taken into account that the effects on parasite growth and
multiplication in vitro might be less pronounced than in vivo –a s
observed in genetic GR deficiency. Thus additional tests such as
parallel application of oxidant stressors and/or determination of
membrane alterations and phagocytosis should be performed for
assessing the antimalarial effects of GR inhibitors. Furthermore
their hemolytic potential needs to be evaluated carefully.
Materials and Methods
Patients
The GR-deficient patient – the index patient – who kindly
agreed to donate blood for this study was a 54-year old woman
whose clinical history has been described before [17,18]. She was
the index patient in a family with GR deficiency who suffered a
hemolytic crisis after eating fava beans. Two siblings – brother and
sister of the index patient, indicated as individual 2 and individual
3, respectively – were also homozygous for GR deficiency [17]. In
all three individuals GR activity in RBCs and leukocytes was
undetectable and could not be stimulated by either riboflavin
ingestion in vivo or FAD addition in vitro [18].
All family members included in this study are fully aware of
their unique enzyme deficiency and have given their written
consent for the research carried out. The research has been
explained to them both in written and oral form. The research was
performed as part of the diagnostic work on the patients’ blood
samples, which is fully approved by the Sanquin Ethical Medical
Committee.
GR activity in GR-deficient, non-infected RBCs and GR-
deficient leukocytes
As previously reported, the GR activity in the patients’ non-
infected RBCs was below the detection limit of our assay, while
leukocytes had 15% of normal activity. However, taking into
account the basal NADPH oxidation rate measured in the absence
of GSSG (14–63 mmoles/min/10
11 cells at 25uC), only minimal
GR activity was present in patient’s or her siblings’ leukocytes
(,5 mmoles/min/10
11 cells at 25uC) [18]. Furthermore neither
non-infected RBCs nor leukocytes of the patient or her siblings
contained detectable amounts of GR protein. In direct compar-
ison, healthy adult control persons (n=100) had GR activities of
2.7–5.8 IU/g hemoglobin in RBCs and 118–164 IU/10
11 leuko-
cytes [18].
GSH levels were already measured and reported for the GR-
deficient patients in 1976. GSH was measured in the red cells of all
family members and found to be normal, with values of 56–63 mg
of GSH per 100 ml of packed red cells [17].
Preparation and shipment of blood samples
For the studies performed in Giessen (infection by 3D7 and K1
P. falciparum strains, parasite cultivation, synchronization, invasion
and multiplication studies, determination of glutathione and
enzyme activities in parasites, drug sensitivity tests), EDTA-blood
samples were taken from the patients and from hematologically
healthy control persons in the Netherlands, immediately shipped
to Germany on crushed ice, and utilized within 24 h. For the
studies performed in Turin (infection by the Palo Alto P. falciparum
strain and parasite cultivation, invasion and multiplication studies,
synchronization of parasite cultures and stage-dependent separa-
tion of infected RBCs, quantification of membrane-bound total
GR Deficiency and Malaria
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phagocytosis with stage-separated infected and control RBCs), full
blood from the GR-deficient individuals and three normal controls
was anticoagulated with CPD, shipped on crushed ice, and utilized
within 24 h of venipuncture. The further processing of the blood
samples is described below.
Cultivation of P. falciparum and preparation of parasite
extracts
In the Giessen lab CQ sensitive (3D7-Netherlands) and resistant
(K1-Southeast Asia) strains of P. falciparum were grown in
continuous culture as described [58] with slight modifications.
Parasites were maintained at 1–10% parasitemia and 3.3%
hematocrit in RPMI 1640 culture medium supplemented with
A
+ RBCs (normal culture conditions) or 0
+ RBCs (for the GR-
deficient patient and a control sample), 4% A
+ human serum,
0.2% lipid-rich bovine serum albumin (Albumax), 9 mM glucose,
0.2 mM hypoxanthine, 2.1 mM L-glutamine, and 22 mg/ml
gentamicin. All incubations were carried out at 37uC, 3% O2,
3% CO2 and 94% N2. Synchronization of parasites in culture to
ring stages was carried out by treatment with 5% (w/v) sorbitol
[59]. The morphology of the parasites as well as the multiplication
rate were determined by light microscopy after Giemsa staining.
Before determining either the glutathione content or the GR
activity in P. falciparum, parasites were grown over 5 cycles (10
days) in their respective RBCs. Trophozoite stage parasites were
then isolated by suspending the RBCs in a 20-fold volume of
buffer containing 7 mM K2HPO4, 1 mM NaH2PO4,1 1 m M
NaHCO3, 58 mM KCl, 56 mM NaCl, 1 mM MgCl2,1 4m M
glucose, and 0.02% saponin for 10 min at 37uC. The pellets were
washed two times in the same saponin buffer for RBC lysis and
one time in PBS (centrifugation for all steps 1,500 g, 5 min, room
temperature). The free parasites were finally diluted in PBS and
disrupted by freezing and thawing three times in the presence of
protease inhibitors (40 ml/ml Complete (Roche) and 1 mg/ml
Pefabloc (Roche)). After centrifugation (ultracentrifuge 100,000 g,
30 min, 4uC), the protein content of the supernatant was
determined by the Bradford method and the extract was used
for the various analyses.
Invasion and multiplication of P. falciparum grown in GR-
deficient RBCs
To determine if P. falciparum can successfully invade and
multiply in GR-deficient RBCs, EDTA full blood was taken from
patients and controls in the Netherlands and shipped at 4uC to the
Giessen lab. About 24 h after venipuncture, plasma and buffy coat
of the blood samples were removed by centrifugation (1,500 g) and
aspiration followed by washing three times in a 10-fold volume of
RPMI 1640 medium (1,500 g, 3 min, 4uC). For some of the
invasion studies control samples freshly taken in Germany were
processed and studied in parallel.
EXPERIMENT 1: Ten ml of RBCs from the index patient (0
+
blood) and two German controls (A
+ and 0
+ blood) each were
added to 300 ml of complete cell culture medium in 48-well plates.
Two ml of parasitized RBCs (3D7, mainly trophozoite stage; final
parasitemia 0.7%) were added to the RBC cultures. The K1 strain
was inoculated for drug sensitivity tests.
EXPERIMENT 2: In a separate experiment, RBCs from the
index patient (0




+ blood). After washing, 0.5 ml of RBCs were added to 15 ml
of cell culture medium and inoculated with 1 ml of parasitized
RBCs (3D7, synchronized to ring stages; this resulted in the same
final parasitemia of 0.7% as in experiment 1).
Determination of total glutathione and PfGR activity in
parasite extracts
For the determination of total glutathione content, 40 mlo f
parasite extract was deproteinized by adding 2 vol of 5% (w/vol)
sulfosalicylic acid; the samples were mixed and centrifuged, and
the supernatant was used for analyses. The glutathione content
was measured by the GR-coupled 5,59-dithio-bis(2-nitrobenzoic
acid, DTNB)-GSH-recycling assay [60]. A standard curve was
prepared using appropriate concentrations of GSH and sulfosa-
licylic acid. P. falciparum (Pf)GR activity in the parasite extracts was
assayed at 25uC with 100 mM NADPH and 1 mM GSSG in
47 mM potassium phosphate, 200 mM KCl, 1 mM EDTA,
pH 6.9. The consumption of NADPH was followed spectropho-
tometrically at 340 nm [61]. Specific activities (mmol/min/mg of
protein) were calculated using the enzyme activities at 25uC and
the protein concentrations of the parasite extracts.
Drug effects on P. falciparum
An isotopic drug sensitivity assay using the semi-automated
microdilution technique [62] was employed to investigate the
effects of CQ, artemisinin, methylene blue, paraquat and sodium
nitroprusside (SNP) on parasites grown in GR-deficient RBCs.
The method is based on the incorporation of radioactive
3H-
hypoxanthine – which is taken up by the parasite as a precursor of
purine deoxynucleotides for DNA and RNA synthesis – and was
modified according to Fivelman [63]. In 96-well microtiter plates
(Nunc
R), a two-fold serial dilution of the starting concentration of
each drug to be tested was carried out. Parasites were incubated at
a parasitemia of 0.125% (.70% ring forms) and 1.25%
hematocrit in hypoxanthine-free medium. After 48 h, 0.5 mCi
3H-hypoxanthine was added into each well and the plates were
incubated for another 24 h. The cells from each well were
harvested on a glass fiber filter (Perkin-Elmer, Rodgau-Ju ¨gesheim,
Germany), washed, and dried. Their radioactivity in counts per
min was considered to be proportional to the respective growth of
P. falciparum in the well. IC50 values (drug concentrations that
produce 50% reduction in the uptake of
3H-hypoxanthine) were
calculated as described in [63].
For statistical analyses of the data on multiplication rates,
biochemical parameters and IC50 values (given as mean values 6
SEM), the unpaired t-test as well as the Mann-Whitney U Test
were employed.
Stage-dependent separation and opsonization of
parasites
P. falciparum parasites (Palo Alto strain, Mycoplasma-free) were
cultivated in normal and GR- deficient RBCs at 2% hematocrit
and synchronized as described [30]. Briefly, schizont stage infected
normal RBCs (parasitemia .95%) were mixed for invasion with
washed GR-deficient or normal RBCs and kept in growth medium
(RPMI 1640, containing 25 mM Hepes, 30 mM glucose, 2 mM
glutamine, 0.02 mM adenine, 24 mM NaHCO3, 32 mg/l genta-
micin, and 10% A
+ decomplemented human plasma) (time 0).
After 19 h incubation in a humidified CO2/air incubator, the
ring-enriched fraction was separated on and collected from a
discontinuous 40/80/90% Percoll gradient, containing mannitol
(6% wt/vol). The bottom Percoll fraction contained non-infected
RBCs and approximately 15–20% rings, morphologically identical
to those of the ring-enriched fraction. After 41 h incubation the
trophozoite-enriched fraction was separated onto and collected
from a discontinuous 10/40/80% Percoll gradient. Rings (after
19 h incubation) as well as trophozoites (after 41 h incubation)
were enriched to approx. 80–85% and approx. 90%, respectively,
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were assessed by light microscopy after Diff-QuikH Fix staining
(Medion Diagnostics GmbH, Du ¨dingen, Switzerland). Non-
infected control RBCs of each donor were incubated and treated
in a similar way without schizont inoculation at time 0. Infected
and non-infected RBCs were washed, rejuvenated for 1 h in PBS-
G, and opsonized with freshly drawn serum of a healthy AB/Rh
+-
donor in a ratio: RBCs/PBS containing 2 mM glucose (PBS-G)/
serum 1/1/2 (vol/vol). Non-opsonized RBCs were incubated in
parallel substituting serum with PBS-G. After 30 min at 37uC cells
(ring-enriched, trophozoite-enriched or non-infected RBCs) were
washed 3 times with PBS-G, adjusted to 50% hematocrit and
analyzed by FACS for surface-bound IgG and complement C3c
fragment, and utilized for the phagocytosis assays with THP-1 cells
and human peripheral monocytes. Total heme and hemichromes
were measured in hypotonic ghosts prepared from the bottom
Percoll fraction of the unseparated, infected GR-deficient and
normal RBCs (see below). The latter procedure was due to the
paucity of the ring material obtained by the enriched ring fraction
(approx. 30–40 ml per individual) sufficient to perform cytofluori-
metric studies but not sufficient for ghost preparation.
Quantification of membrane-bound total heme and
hemichromes in ghosts prepared from stage-separated
infected RBCs
Heme bound to the cytoplasmic face of the membrane as
hemoglobin and insoluble hemichromes was analyzed in the
hypotonic ghosts [64] prepared under non-reducing conditions in
the presence of CompleteH protease inhibitor cocktail from the
bottom Percoll fraction of the unseparated, infected GR-deficient
and normal RBCs [22]. This fraction contained approximately
15–20% rings. Every ghost preparation was divided into two
aliquots. A first aliquot of 10 ml ghosts was solubilized for 3 h at
4uC in 1 ml of 0.1 N NaOH containing 3 mM EDTA and 0.05%
(vol/vol) Triton X100 to quantify the total heme content
(hemoglobin + insoluble hemichromes). A second aliquot of
10 ml ghosts was solubilized for 1 h at room temperature in 1 ml of
PBS containing 3 mM EDTA and 0.05% (vol/vol) Triton X100
and used to quantify hemoglobin. Heme from both ghost aliquots
was quantified by measuring the heme-dependent luminol-
enhanced luminescence as described [65]. Each luminescence
measurement (2 mL aliquots) was repeated 3–4 times. Inter-
measurement variability never exceeded 2–3%. Results obtained
from cell samples that contained approx. 15–20% rings were
extrapolated to 100% rings using the calculation suggested by
Cappadoro et al. [20]. The hemichrome content was calculated
from the difference between total heme and hemoglobin heme.
Hemichrome heme was the major component of total heme in
control rings (88% of total heme), index patient (96%), individual 2
(89%) and individual 3 (87%), while membrane-bound hemoglo-
bin was a minor fraction of total heme.
Quantification of complement C3c fragment and IgG by
flow cytometry
Ten million ring- or trophozoite-infected and non-infected
normal or GR-deficient RBCs were incubated for 30 min at room
temperature in 50 ml of PBS-G, with or without the primary rabbit
anti-human complement C3c fragment antibody or anti-human
IgG antibody (Sigma, Milano, Italy), at a 1:400 dilution,
respectively. Complement C3c fragment is the stable derivative
of C3b/C3b2 opsonins [66]. Thereafter infected RBCs and non-
infected controls were washed twice, suspended in 50 ml PBS-G,
and incubated for 30 min at room temperature with anti-rabbit
IgG-FITC antibody (goat) at 1:400. At the end of the incubation,
cells were washed twice with 200 ml PBS-G, suspended in PBS-G,
and analyzed on a BD FACSCalibur Flow Cytometer using Cell
Quest software (BD Biosciences). Events were displayed on green
fluorescence (FL1) versus forward scatter (FSC) dot plots or FL1
versus events number histogram. RBCs were gated on light scatter
characteristics, and a total of at least 30,000 events in gating were
collected for each sample. Data analysis was done with WinMDI
software.
Phagocytosis of stage-separated infected and control
RBCs by THP-1 cells and human mononuclear cells
The phagocytosis assay was performed utilizing the human
monocytic cell line THP-1 or human mononuclear cells.
1. THP-1 cells were maintained at 0.2610
6 cells/ml in RPMI
1640 medium supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and
100 mg/ml streptomycin. The phagocytic ability of THP-1 cells
was stimulated by supplementing IFN-gamma (50 U/ml) and
TNF (250 U/ml) to the cell suspension 30 h before the start of
phagocytosis. Shortly before phagocytosis, cells were washed three
times with RPMI 1640 medium and resuspended in Macrophage-
SFM medium supplemented with 10% heat-inactivated FBS to
obtain 150,000 cells/300 ml medium. Ring- or trophozoite-
infected and non-infected normal or GR-deficient RBCs were
fluorescent-labeled for the phagocytosis assay during 10 min
incubation at room temperature with 0.5 mM carboxyfluorescein
diacetate, succinimidyl ester, (CFDA-SE, Sigma, Milano, Italy) in
PBS-G at 0.05% hematocrit. Labeling was stopped by adding 2 ml
of heat-inactivated FBS for 5 min. RBCs were then washed three
times with PBS-G and co-incubated with THP-1 cells at a THP-
1:RBC- ratio of 1:100 in round-bottom polypropylene tubes at
37uC for 2.5 h (CO2 5%). At the end of the incubation, non-
ingested RBCs were lysed with 3.5 ml of ice-cold distilled water for
2 min. Physiologic osmolarity was restored by adding 10-times
concentrated PBS. Cells were finally washed with cold PBS +1%
FBS and analyzed with a BD FACSCalibur Flow Cytometer using
Cell Quest software (BD Biosciences). Events were displayed on
green fluorescence (FL1) versus forward scatter (FSC) dot plots or
FL1 versus events number histogram. THP-1 live cells were gated
on light scatter characteristics, and a total of at least 30,000 events
in gating were collected for each sample. Data analysis was done
with WinMDI software.
2. Human mononuclear cells were separated by Ficoll
separation from buffy coats of healthy donors freshly discarded
from the local blood bank, suspended in Macrophage-SFM
medium (Invitrogen, Carlsbad, CA), and adhered to 24-well cell
culture plates as described [67]. Phagocytosis was started by the
addition of 100 opsonized ring- or trophozoite-infected or non-
infected normal or GR-deficient RBCs per monocyte, stopped
after 3 h incubation in the CO2-incubator, and non-ingested
RBCs were removed by lysis and 4 washing steps. Phagocytosis
was quantified by measuring the heme-dependent luminol-
enhanced luminescence of ingested hemoglobin-heme as described
[65].
Supporting Information
Figure S1 Membrane-bound hemichromes, phagocytosis, com-
plement C3c fragment, and autologous IgG in/of GR-deficient
and GR-sufficient RBCs - comparison with healthy Italian donors.
Data from Figure 1 and Figure 2 of the manuscript were
compared to ring-infected and non-infected GR-sufficient control
RBCs prepared from 24–36 h old blood (kept at +4uC) from 7
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Found at: doi:10.1371/journal.pone.0007303.s001 (1.65 MB TIF)
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